Peripheral Stent Implants Market
The Peripheral Stent Implants Market is expected to grow from USD 345.00 Million in 2022 to USD 588.36 Million by 2030, at a CAGR of 6.90% during the forecast period.
Get the Sample Report: https://www.reportprime.com/enquiry/sample-report/11376
Peripheral Stent Implants Market Size
Peripheral stent implants are medical devices used to treat blockages in peripheral arteries, such as those in the legs and arms. The Peripheral Stent Implants market research report segments the market based on type (Bare Metal Stents, Covered Stents, Drug Eluting Stents), application (Hospitals, Ambulatory Surgical Centers), region (North America, Asia Pacific, Middle East, Africa, Australia and Europe) and key players (Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical, Inc., Cardinal Health, Inc., iVascular SLU, Medtronic Plc., Terumo Corporation, W. L. Gore & Associates Inc.). Additionally, the report explores regulatory and legal factors specific to market conditions, such as product approvals and healthcare policies, that can impact the growth of the peripheral stent implants market.
Peripheral Stent Implants Market Key Player
Abbott Laboratories
B. Braun Melsungen AG
Biotronik SE & Co. KG
Boston Scientific Corporation
Cook Medical, Inc
Buy Now & Get Exclusive Discount on this https://www.reportprime.com/enquiry/request-discount/11376
Peripheral Stent Implants Market Segment Analysis
The Peripheral Stent Implants market comprises medical devices designed to permanently expand and support the blocked or narrowed blood vessels in the peripheral arteries. The market's growth is driven by increasing incidences of peripheral artery disease (PAD) due to aging populations and an increase in lifestyle-related illnesses such as diabetes, hypertension, and obesity. The market has seen promising revenue growth over the years, with growing acceptance of minimally invasive treatment procedures and advancements in technology offering better treatment options.
The latest trend observed in the market is the increasing adoption of bioresorbable vascular scaffolds or stents (BVS) over the traditional metallic stents. These BVS stents are made of biodegradable polymers that eventually get absorbed into the body, and provide better long-term outcomes compared to metallic stents. Additionally, technological advancements in the manufacturing of these stents have improved their strength and flexibility, providing better outcomes for patients with PAD.
However, the market still faces major challenges like the high cost associated with the development of innovative stents, reimbursement issues, and the stringent regulatory scenario. The lack of skilled professionals capable of performing the procedures is another challenge faced by the market in the developing countries.
The main findings of the report suggest that the Peripheral Stent Implants market has seen impressive growth and is expected to grow at a CAGR of 6.90% from 2022 to 2030. The report recommends that the industry should focus on offering more innovative and affordable stents to address the market's challenges. It also suggests improvement in clinical trials and collaborations between the key players in the market to enhance research and development in this area.
In conclusion, the Peripheral Stent Implants market has seen significant growth in recent years, mainly due to a rise in the aging population and a rise in lifestyle-related illnesses. The market still has some challenges to overcome, such as regulatory issues and high costs associated with innovative stent development. Still, with technological advancements and the increasing acceptance of minimally invasive procedures, the highlights of the market will be better observed.
This report covers impact on COVID-19 and Russia-Ukraine wars in detail.
Purchase This Report: https://www.reportprime.com/checkout?id=11376&price=3590
Market Segmentation (by Application):
Hospitals
Ambulatory Surgical Centers
Information is sourced from www.reportprime.com
Top comments (0)